There were highly significant improvements in the peak and predicted peak oxygen consumption (VO 2 peak) and the VE/VCO 2 slope between the baseline and the 12-month follow-up.
← all excerpts
Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction.
1
—
—